Lasting Benefit With Nivo Plus Ipi in Advanced Liver Cancer ...Middle East

News by : (Medscape) -
Long-term follow-up data show a continued benefit in advanced hepatocellular carcinoma (HCC) with nivolumab and ipilimumab after disease progression on sorafenib in the Checkmate 040 trial. Medscape Medical News

Read More Details
Finally We wish PressBee provided you with enough information of ( Lasting Benefit With Nivo Plus Ipi in Advanced Liver Cancer )

Also on site :

Most Viewed News
جديد الاخبار